OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus
David W. Hutton, Lisa A. Prosser, Angela M. Rose, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126294-126294
Closed Access | Times Cited: 4
David W. Hutton, Lisa A. Prosser, Angela M. Rose, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126294-126294
Closed Access | Times Cited: 4
Showing 4 citing articles:
Kosteneffizienz von Impfungen: Über die Komplexität gesundheitsökonomischer Analysen zur Influenza‑, SARS-CoV-2- und RSV-Impfung
Peter Klimek
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2025)
Open Access
Peter Klimek
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2025)
Open Access
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis
Xiao Li, Lander Willem, Caroline Klint Johannesen, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Xiao Li, Lander Willem, Caroline Klint Johannesen, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: A multi-country analysis
Xiao Li, Lander Willem, Caroline Klint Johannesen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Xiao Li, Lander Willem, Caroline Klint Johannesen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States
Elizabeth M. La, James E. Graham, David Singer, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Elizabeth M. La, James E. Graham, David Singer, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options
Matteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1317-1317
Open Access
Matteo Riccò, Bahaa Abu-Raya, Giancarlo Icardi, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1317-1317
Open Access
